Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07795255Phase 3Not yet recruiting
A Phase 3 trial of lidocaine 10% oropharyngeal spray in bladder cancer, hematuria, sponsored by Florian Schroeck. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07795255.